Newsletter | 01 July 2001 Access News 5, Focus on the Access Campaign, July 2001 INTELLECTUAL PROPERTY AND TRADE The Access Campaign and its different focuses are addressed in this edition of AccessNews. Drug pricing, ARV care, South Africa's victory for the developing world, sleeping sickness and malaria are these editions highlights. Read, watch, share Filter by - Any -BlogEventsFeature storyInfographicInterviewIssue briefLetterNewsletterOpinion articlePress releaseReportResearch articleSpeechSpotlightStatementTechnical briefTopic overviewVideo Photograph by James Keogh/Wostok Press Events Events | 03 December 2012 Intellectual property and trade Research and development Vaccines MSF at the 2012 GAVI Partners Forum Opinion article | 30 November 2012 HIV/AIDS Intellectual property and trade Canada’s role in ‘getting to zero’ on HIV 4 min Feature story | 29 November 2012 Intellectual property and trade Research and development MSF response to outcome of WHO negotiations on medical R&D Letter | 27 November 2012 Intellectual property and trade Research and development Open letter to WHO Member States at follow-up meeting on the report of the CEWG 6 min Opinion article | 27 November 2012 Intellectual property and trade Research and development Tuberculosis PLOS Blogs: Children with TB – Global Interest at Last 3 min Photograph by Giorgos Moutafis Feature story Feature story | 27 November 2012 HIV/AIDS Intellectual property and trade Eswatini Swaziland: Trying out new approaches to HIV treatment 7 min Speech | 25 November 2012 HIV/AIDS Intellectual property and trade Research and development Tuberculosis Vaccines MSF Intervention at Member States follow-up meeting on CEWG, November 2012 Statement | 22 November 2012 Intellectual property and trade Why Roche can decrease its prices and why it has a moral obligation to do so Load More
Photograph by James Keogh/Wostok Press Events Events | 03 December 2012 Intellectual property and trade Research and development Vaccines MSF at the 2012 GAVI Partners Forum
Opinion article | 30 November 2012 HIV/AIDS Intellectual property and trade Canada’s role in ‘getting to zero’ on HIV 4 min
Feature story | 29 November 2012 Intellectual property and trade Research and development MSF response to outcome of WHO negotiations on medical R&D
Letter | 27 November 2012 Intellectual property and trade Research and development Open letter to WHO Member States at follow-up meeting on the report of the CEWG 6 min
Opinion article | 27 November 2012 Intellectual property and trade Research and development Tuberculosis PLOS Blogs: Children with TB – Global Interest at Last 3 min
Photograph by Giorgos Moutafis Feature story Feature story | 27 November 2012 HIV/AIDS Intellectual property and trade Eswatini Swaziland: Trying out new approaches to HIV treatment 7 min
Speech | 25 November 2012 HIV/AIDS Intellectual property and trade Research and development Tuberculosis Vaccines MSF Intervention at Member States follow-up meeting on CEWG, November 2012
Statement | 22 November 2012 Intellectual property and trade Why Roche can decrease its prices and why it has a moral obligation to do so
